A Multi-Center Trial of Nepicastat for Cocaine Dependence

Status:	Completed
Conditions:	Psychiatric, Pulmonary
Therapuetic Areas:	Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:	No
Age Range:	18 - Any
Updated:	5/5/2014
Start Date:	April 2013
End Date:	August 2014

Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence

The objective of this study is to evaluate the safety and efficacy of Nepicastat in
improving the number of subjects that achieve abstinence from cocaine and reducing cocaine
use in subjects with cocaine dependence.

Inclusion Criteria:

- Be at least 18 years of age

- Is seeking treatment for cocaine dependence

- Is able to understand and provide written informed consent

- Has completed all psychological assessments and procedures required during the 7 - 14
day screening period

- If female, agrees to use an acceptable method of birth control

- Is, in the opinion of the Investigator, likely to complete the 11-week Treatment
Phase of the study

Exclusion Criteria:

- Please contact the study site for more information

We found this trial at

sites

Columbia University Medical Center

630 W 168th St
New York, New York

212-305-2862